Delivery Order SPE2DB20D1047-SPE2DB25FF36Y
Award Date
1/15/25
Potential Completion Date
1/16/25
Potential Value
$2.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $1,334.24, is for the delivery of Quillivant XR 25 mg/5 ml suspension in 60 ml bottles. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 8, 2025. The contract does not have a set-aside designation, indicating it was open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,971.30, is for the delivery of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product. The contract is a firm fixed-price delivery order with a period of performance through March 31, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,318.18, is for the delivery of Quillivant XR 25 mg/5 ml suspension product. The contract is a Firm Fixed Price Delivery Order with a completion date of March 31, 2025. This contract award is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,051.36, is for the delivery of the drug Quillivant XR 25 mg/5 ml suspension in 180 ml containers. This is a Firm Fixed Price delivery order contract with an ultimate completion date of April 4, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $2,180.10, is for the delivery of Quillivant XR 25 mg/5 ml suspension (180 ml), a pharmaceutical product. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of April 7, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,051.36, is for the delivery of Quillivant XR 25 mg/5 ml suspension in 150 ml bottles. This is a Firm Fixed Price Delivery Order contract with a period of performance through February 3, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,310.76, is a delivery order for the supply of Quillivant XR 25 mg/5 ml suspension in 180 ml bottles. The contract has a firm fixed price and an ultimate completion date of April 15, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,314.20, is a Firm Fixed Price Delivery Order for the supply of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product. The contract has an ultimate completion date of January 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product, with a ceiling value of $1,051.36 and a period of performance ending on March 7, 2025. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,005.90 firm fixed-price delivery order is for the supply of Quillivant XR 25 mg/5 ml suspension, a prescription medication. The contract has an ultimate completion date of January 29, 2025 and was awarded on January 28, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at...